Skip to content
★ Sign in to follow
EM

Elizabeth M. Anderson

Board Director
Director
Insider activity · 24 months0 buys7 salesCumulative net flow
Total declarations
38
Companies
3
▲ Purchases (0 ops.)
—
▼ Sales (10 ops.)
€4.6M

Latest filing published 24 Sept 2026 for Revolution Medicines, Inc., €4,951.

Filing timeline

BuySale
Elizabeth M. Anderson

Insider track record

Disclosed buys
0
Disclosed sells
10
Signal history

Elizabeth M. Anderson: trading record in brief

November 2025 groups two of the three largest sales by Elizabeth M. Anderson at INSMED Inc: EUR 1,683,894 on November 14 and EUR 888,890 on November 24. The third, EUR 836,854, dates from September 22, 2026 at Revolution Medicines, Inc. The 10 sales on file total EUR 4.6 million (EUR 4,642,536), median EUR 219,113. No purchase.

Anderson is a Director of Revolution Medicines, Inc. (19 filings), INSMED Inc (11) and Biomarin Pharmaceutical Inc (8). The record holds 38 filings from November 8, 2018 to September 24, 2026, of which 25 are grants, 1 an option exercise and 2 of another kind, published a median of 2 days after the trade.

The pace is discreet, between 1 and 6 filings a year through 2025, then 11 in 2026. The last twelve months count 13 filings, 7 of them sales.

8 of Anderson's market trades fall within 30 days of a trade by Jack Anders, 8 of Margaret A. Horn, 8 of Mark A. Goldsmith and 8 of Stephen Michael Kelsey, always in the same direction, at Revolution Medicines, Inc.

Companies and markets linked to Elizabeth M. Anderson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations38 total

25 of 38 declarations